ImQuest BioSciences is a preclinical and infectious disease Contract Research Organization (CRO) based in Frederick, MD. They specialize in providing expert services for the evaluation of novel pharmaceutical products targeting viruses, bacteria, cancer, and inflammatory diseases. With a diverse client portfolio that includes pharmaceutical companies, biotechnology companies, start-ups, and academic investigators, ImQuest offers comprehensive compound screening, drug target validation, mechanism of action analysis, and toxicity evaluations for small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies, and vaccines.
ImQuest BioSciences offers a wide range of preclinical and infectious disease specialty services, including virus and bacteria testing, in vitro toxicology, cancer testing, and drug screening support. They also provide custom assay development and outsourced research and development support. With decades of antiviral expertise, extensive immunology and microbiology capabilities, and a focus on R&D support, ImQuest BioSciences is dedicated to helping clients develop innovative solutions for the treatment and prevention of diseases.
Generated from the website